ID
6422
Description
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML
Keywords
Versions (2)
- 11/2/13 11/2/13 -
- 12/22/14 12/22/14 - Martin Dugas
Uploaded on
December 22, 2014
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Studienende / Studienabbruch EudraCT 2008-004583-40 Akute myeloische Leukämie(AML) AML alle außer FAB M3
Studienende / Studienabbruch
- StudyEvent: Akute myeloische Leukämie(AML) AML alle außer FAB M3
Description
Early Termination of Clinical Trials
Alias
- UMLS CUI 2011AB
- C2718058
Description
Early termination of clinical trial
Data type
date
Alias
- Code-1
- Early termination of clinical trial
- UMLS CUI 2011AB
- C2718058
Description
Reason
Data type
integer
Alias
- UMLS CUI 2011AB
- C0392360
- SNOMEDCT_2012_01_31
- 410666004
- LOINC Version 232
- MTHU008862
Description
Other reason
Data type
string
Alias
- Code-1
- Other
- UMLS CUI 2011AB
- C0205394
- SNOMEDCT_2012_01_31
- 74964007
- Code-2
- Reason
- UMLS CUI 2011AB
- C0392360
- SNOMEDCT_2012_01_31
- 410666004
- LOINC Version 232
- MTHU008862
- Code-3
- Free Text Format
- UMLS CUI 2011AB
- C2348713
Description
AE-No
Data type
integer
Alias
- Code-1
- Adverse event
- UMLS CUI 2011AB
- C0877248
- MedDRA 14.1
- 10060933
- LOINC Version 232
- MTHU014542
- Code-2
- Number
- UMLS CUI 2011AB
- C0237753
- SNOMEDCT_2012_01_31
- 260299005
- LOINC Version 232
- MTHU024869
Description
Remission status at date of study termination
Data type
integer
Alias
- Code-1
- Remission
- UMLS CUI 2011AB
- C0544452
- SNOMEDCT_2012_01_31
- 277022003
- Code-2
- Status
- UMLS CUI 2011AB
- C0449438
- SNOMEDCT_2012_01_31
- 263490005
- LOINC Version 232
- MTHU015827
- Code-3
- Date
- UMLS CUI 2011AB
- C0011008
- SNOMEDCT_2012_01_31
- 410671006
- LOINC Version 232
- MTHU021546
- Code-4
- Study Terminated
- UMLS CUI 2011AB
- C2348570
Description
Signature
Alias
- UMLS CUI 2011AB
- C1519316
Description
Datum
Data type
date
Alias
- UMLS CUI 2011AB
- C0011008
- SNOMEDCT_2012_01_31
- 410671006
- LOINC Version 232
- MTHU021546
Description
Name/Unterschrift Prüfarzt
Data type
string
Alias
- Code-1
- Name
- UMLS CUI 2011AB
- C0027365
- LOINC Version 232
- MTHU008539
- Code-2
- Signature
- UMLS CUI 2011AB
- C1519316
- Code-3
- Study
- UMLS CUI 2011AB
- C0008976
- SNOMEDCT_2012_01_31
- 110465008
- Code-4
- Physician
- UMLS CUI 2011AB
- C0031831
- SNOMEDCT_2012_01_31
- 309343006
- LOINC Version 232
- MTHU010489
- HL7 V3 2006_05
- PHYS
Similar models
Studienende / Studienabbruch
- StudyEvent: Akute myeloische Leukämie(AML) AML alle außer FAB M3
C0205272 (UMLS CUI 2011AB)
17854005 (SNOMEDCT_2012_01_31)
Study end (Code-2)
C2983670 (UMLS CUI 2011AB)
C0004475 (UMLS CUI 2011AB)
88551000 (SNOMEDCT_2012_01_31)
Date last dose (Code-2)
C1762893 (UMLS CUI 2011AB)
MTHU014073 (LOINC Version 232)
C2718058 (UMLS CUI 2011AB)
CL425202 (UMLS CUI 2011AB)
not (Code-2)
C1518422 (UMLS CUI 2011AB)
Meet (Code-3)
C1550543 (UMLS CUI 2011AB)
FLFS (HL7 V3 2006_05)
CL425201 (UMLS CUI 2011AB)
Present (Code-2)
C0150312 (UMLS CUI 2011AB)
52101004 (SNOMEDCT_2012_01_31)
C0877248 (UMLS CUI 2011AB)
10060933 (MedDRA 14.1)
MTHU014542 (LOINC Version 232)
CL414904 (UMLS CUI 2011AB)
Treatment failure (Code-2)
C0162643 (UMLS CUI 2011AB)
10066901 (MedDRA 14.1)
263855007 (SNOMEDCT_2012_01_31)
419620001 (SNOMEDCT_2012_01_31)
E11080 (CTCAE 1105E)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Reason (Code-2)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008862 (LOINC Version 232)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Reason (Code-2)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008862 (LOINC Version 232)
Free Text Format (Code-3)
C2348713 (UMLS CUI 2011AB)
C0877248 (UMLS CUI 2011AB)
10060933 (MedDRA 14.1)
MTHU014542 (LOINC Version 232)
Number (Code-2)
C0237753 (UMLS CUI 2011AB)
260299005 (SNOMEDCT_2012_01_31)
MTHU024869 (LOINC Version 232)
C0544452 (UMLS CUI 2011AB)
277022003 (SNOMEDCT_2012_01_31)
Status (Code-2)
C0449438 (UMLS CUI 2011AB)
263490005 (SNOMEDCT_2012_01_31)
MTHU015827 (LOINC Version 232)
Date (Code-3)
C0011008 (UMLS CUI 2011AB)
410671006 (SNOMEDCT_2012_01_31)
MTHU021546 (LOINC Version 232)
Study Terminated (Code-4)
C2348570 (UMLS CUI 2011AB)
C0677874 (UMLS CUI 2011AB)
103338009 (SNOMEDCT_2012_01_31)
Morphology (Code-2)
C0332437 (UMLS CUI 2011AB)
116676008 (SNOMEDCT_2012_01_31)
MTHU008051 (LOINC Version 232)
leukemia (Code-3)
C0023418 (UMLS CUI 2011AB)
93143009 (SNOMEDCT_2012_01_31)
10024288 (MedDRA 14.1)
C95.9 (ICD-10-CM Version 2010)
208.9 (ICD-9-CM Version 2011)
Free (Code-4)
C0332296 (UMLS CUI 2011AB)
37837009 (SNOMEDCT_2012_01_31)
Status (Code-5)
C0449438 (UMLS CUI 2011AB)
263490005 (SNOMEDCT_2012_01_31)
MTHU015827 (LOINC Version 232)
CL414904 (UMLS CUI 2011AB)
Treatment failure (Code-2)
C0162643 (UMLS CUI 2011AB)
10066901 (MedDRA 14.1)
Relapse (Code-3)
C0035020 (UMLS CUI 2011AB)
263855007 (SNOMEDCT_2012_01_31)
261665006 (SNOMEDCT_2012_01_31)
C0027365 (UMLS CUI 2011AB)
MTHU008539 (LOINC Version 232)
Signature (Code-2)
C1519316 (UMLS CUI 2011AB)
Study (Code-3)
C0008976 (UMLS CUI 2011AB)
110465008 (SNOMEDCT_2012_01_31)
Physician (Code-4)
C0031831 (UMLS CUI 2011AB)
309343006 (SNOMEDCT_2012_01_31)
MTHU010489 (LOINC Version 232)
PHYS (HL7 V3 2006_05)